As nations around the globe race to find different solutions to prevent the further spread of the dreaded COVID-19 virus, Israel gave interim approval for the sale of Canadian-based biotech company SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) branded as Enovid. SaNOtize developed and patented the platform technology that allows for the topical delivery of Nitric Oxide (the formula written as NO) for treating a variety of bacterial, fungal, and viral diseases. Utilizing the unique antimicrobial and immunomodulating properties of NO to treat both dermatologic and respiratory diseases, the production of this nose spray that claims to kill...